These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 10636751

  • 1. Spironolactone in patients with heart failure.
    Larkin RJ, Atlas SA, Donohue TJ.
    N Engl J Med; 2000 Jan 13; 342(2):132-3; author reply 133-4. PubMed ID: 10636751
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tolerability of spironolactone as adjunctive treatment for heart failure in patients over 75 years of age.
    Dinsdale C, Wani M, Steward J, O'Mahony MS.
    Age Ageing; 2005 Jul 13; 34(4):395-8. PubMed ID: 15955761
    [No Abstract] [Full Text] [Related]

  • 5. [Late drug-induced hyperkalemia in a patient with congestive heart failure].
    Konopa J, Bułło B, Rutkowski B.
    Przegl Lek; 2005 Jul 13; 62(7):732-3. PubMed ID: 16463712
    [Abstract] [Full Text] [Related]

  • 6. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M, Takada M, Hirooka K, Isobe F, Yasumura Y.
    J Clin Pharm Ther; 2005 Dec 13; 30(6):603-10. PubMed ID: 16336294
    [Abstract] [Full Text] [Related]

  • 7. Spironolactone for heart failure.
    Med Lett Drugs Ther; 1999 Sep 10; 41(1061):81-2. PubMed ID: 10505071
    [No Abstract] [Full Text] [Related]

  • 8. Drug safety in patients with heart failure.
    Juurlink DN, Hansten PD.
    Arch Intern Med; 2005 Jan 10; 165(1):118. PubMed ID: 15642888
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Study warns of danger of combining spironolactone and ACE inhibitors in heart patients.
    Gottlieb S.
    BMJ; 2004 Aug 21; 329(7463):420. PubMed ID: 15321896
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Drug-related hyperkalemia resulted from spironolactone and angiotensin converting enzyme inhibitors therapy].
    Dutka M, Dzielski T, Wojciechowska J, Heller L, Trybus M.
    Pol Merkur Lekarski; 1999 Aug 21; 7(38):69-70. PubMed ID: 10522422
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [In the age of ACE inhibitors are there still indications for spironolactone in heart failure?].
    Böhm M.
    Internist (Berl); 1995 Feb 21; 36(2):179-80. PubMed ID: 7737809
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hyperkalemia after the publication of RALES.
    Newsome BB, Warnock DG.
    N Engl J Med; 2004 Dec 02; 351(23):2448-50; author reply 2448-50. PubMed ID: 15580678
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.